-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Angel Yeast Co.
, Ltd.
(hereinafter referred to as "Angel Yeast") and Beijing Microstructure Factory Biotechnology Co.
, Ltd.
(hereinafter referred to as "Microstructure Factory") formally signed a cooperation agreement
.
The two parties will form a joint venture company "Weiqi Bio" to jointly promote the industrialization of synthetic biology technology, and start the construction of a PHA production base with an annual output of 30,000 tons in Yichang, Hubei (hereinafter referred to as the "Project")
.
This project is the largest PHA production line among the proposed domestic production capacity, and the third largest PHA production line in the world after Kaneka of Japan and Danimer Scientific of the United States
.
The registered address of Hubei Weiqi Biotechnology Co.
, Ltd.
(subject to industrial and commercial registration) is located in Xiaoting District, Yichang City, Hubei Province
.
The registered capital of the joint venture is 100 million yuan, of which Microstructure Workshop will contribute 60 million yuan in cash, accounting for 60% of the shares; Angel Yeast will invest 40 million yuan in cash, accounting for 40% of the shares
.
The business scope includes the production and sales of PHA related products
.
According to the plan, during the construction of the 30,000-ton PHA production base, the joint venture company will fully combine the technical advantages of the micro-purchase factory with the production capacity and fermentation advantages of Angel Yeast, and use the existing equipment to simultaneously carry out the trial production of 5,000 tons of PHA production line.
production supply market
.
The production line can produce a variety of PHA products, and it will also be the production line that can produce the most types of PHA in the world.
Based on the "Next Generation Industrial Biotechnology" platform, the first mass production production line will scientifically produce a blend of PHB and P34HB.
dozens of materials
.
Including but not limited to: PHB, P34HB, P34HBHV, PHBHHx, PHB5HV, P3HP3HB, P4HB, PHBV, trimeric PHA, functional PHA,
etc.
